220 related articles for article (PubMed ID: 15490420)
1. Advanced glycation end-products and peritoneal sclerosis.
Nakamura S; Niwa T
Semin Nephrol; 2004 Sep; 24(5):502-5. PubMed ID: 15490420
[TBL] [Abstract][Full Text] [Related]
2. Role of advanced glycation end products and growth factors in peritoneal dysfunction in CAPD patients.
Nakamura S; Tachikawa T; Tobita K; Miyazaki S; Sakai S; Morita T; Hirasawa Y; Weigle B; Pischetsrieder M; Niwa T
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S61-7. PubMed ID: 12612955
[TBL] [Abstract][Full Text] [Related]
3. Localization of imidazolone in the peritoneum of capd patients: a factor for a loss of ultrafiltration.
Nakamura S; Miyazaki S; Sakai S; Morita T; Hirasawa Y; Niwa T
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S107-10. PubMed ID: 11576933
[TBL] [Abstract][Full Text] [Related]
4. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis.
Izumotani T; Ishimura E; Yamamoto T; Otoshi T; Okuno S; Inaba M; Kim M; Nishizawa Y
Nephron; 2001 Sep; 89(1):43-9. PubMed ID: 11528231
[TBL] [Abstract][Full Text] [Related]
5. Expression of heat shock proteins 47 and 70 in the peritoneum of patients on continuous ambulatory peritoneal dialysis.
Shioshita K; Miyazaki M; Ozono Y; Abe K; Taura K; Harada T; Koji T; Taguchi T; Kohno S
Kidney Int; 2000 Feb; 57(2):619-31. PubMed ID: 10652040
[TBL] [Abstract][Full Text] [Related]
6. Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Yang LY; Chen A; Huang TP
Am J Nephrol; 1998; 18(6):513-9. PubMed ID: 9845827
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration.
Honda K; Nitta K; Horita S; Yumura W; Nihei H; Nagai R; Ikeda K; Horiuchi S
Nephrol Dial Transplant; 1999 Jun; 14(6):1541-9. PubMed ID: 10383022
[TBL] [Abstract][Full Text] [Related]
8. Possible pathologic involvement of receptor for advanced glycation end products (RAGE) for development of encapsulating peritoneal sclerosis in Japanese CAPD patients.
Numata M; Nakayama M; Hosoya T; Hoff CM; Holmes CJ; Schalling M; Nordfors L; Lindholm B
Clin Nephrol; 2004 Dec; 62(6):455-60. PubMed ID: 15630905
[TBL] [Abstract][Full Text] [Related]
9. Imaging features of encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients.
Ti JP; Al-Aradi A; Conlon PJ; Lee MJ; Morrin MM
AJR Am J Roentgenol; 2010 Jul; 195(1):W50-4. PubMed ID: 20566781
[TBL] [Abstract][Full Text] [Related]
10. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
[TBL] [Abstract][Full Text] [Related]
11. [Encapsulating peritonitis during continuous ambulatory peritoneal dialysis. A physiopathologic hypothesis].
Verger C; Celicout B; Larpent L; Goupil A
Presse Med; 1986 Sep; 15(28):1311-4. PubMed ID: 2950390
[TBL] [Abstract][Full Text] [Related]
12. Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: one center's experience and review of the literature.
Afthentopoulos IE; Passadakis P; Oreopoulos DG; Bargman J
Adv Ren Replace Ther; 1998 Jul; 5(3):157-67. PubMed ID: 9686626
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis.
Dobbie JW
Perit Dial Int; 1992; 12(1):14-27. PubMed ID: 1347465
[TBL] [Abstract][Full Text] [Related]
14. Factors increasing severity of peritonitis in long-term peritoneal dialysis patients.
Park MS
Adv Ren Replace Ther; 1998 Jul; 5(3):185-93. PubMed ID: 9686629
[TBL] [Abstract][Full Text] [Related]
15. Regulation of CCN2/CTGF and related cytokines in cultured peritoneal cells under conditions simulating peritoneal dialysis.
Leung JC; Chan LY; Tam KY; Tang SC; Lam MF; Cheng AS; Chu KM; Lai KN
Nephrol Dial Transplant; 2009 Feb; 24(2):458-69. PubMed ID: 18805993
[TBL] [Abstract][Full Text] [Related]
16. Sclerosing peritonitis with mural bowel fibrosis in a patient on long-term CAPD.
Hauglustaine D; van Meerbeek J; Monballyu J; Goddeeris P; Lauwerijns J; Michielsen P
Clin Nephrol; 1984 Sep; 22(3):158-62. PubMed ID: 6488597
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of an AGE, a ligand for macrophage receptor, in peritoneum of CAPD patients.
Nakamura S; Tobita K; Tachikawa T; Akamatsu S; Ohno Y; Kan A; Katsuragawa M; Yasumura K; Miyazaki S; Sakai S; Morita T; Hirashawa Y; Niwa T
Kidney Int Suppl; 2003 May; (84):S152-7. PubMed ID: 12694334
[TBL] [Abstract][Full Text] [Related]
18. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis.
Mateijsen MA; van der Wal AC; Hendriks PM; Zweers MM; Mulder J; Struijk DG; Krediet RT
Perit Dial Int; 1999; 19(6):517-25. PubMed ID: 10641771
[TBL] [Abstract][Full Text] [Related]
19. Pyridoxal phosphate and hepatocyte growth factor prevent dialysate-induced peritoneal damage.
Nakamura S; Niwa T
J Am Soc Nephrol; 2005 Jan; 16(1):144-50. PubMed ID: 15563557
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal functional parameters after five years on continuous ambulatory peritoneal dialysis (CAPD): the effect of late peritonitis.
Selgas R; Muñoz J; Cigarran S; Ramos P; L-Revuelta K; Escuin F; Miguel JL
Perit Dial Int; 1989; 9(4):329-32. PubMed ID: 2577360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
